发明名称 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRIDAE VIRAL INFECTIONS
摘要 A compound is selected from the structural formulae depicted in FIG. 1 or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a compound selected from the structural formulae depicted in FIG. 1 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier of excipient. A method of treating a HCV infection in a subject comprises administering to the subject a therapeutically effective amount of selected from the structural formulae depicted in FIG. 1 or a pharmaceutically acceptable salt thereof. A method of inhibiting or reducing the activity of HCV polymerase in a subject or in a biological in vitro sample comprises administering to the subject or to the sample a therapeutically effective amount of selected from the structural formulae depicted in FIG. 1 or a pharmaceutically acceptable salt thereof.
申请公布号 US2014065103(A1) 申请公布日期 2014.03.06
申请号 US201313767347 申请日期 2013.02.14
申请人 VERTEX PHARMACEUTICALS INCORPORATED;VERTEX PHARMACEUTICALS INCORPORATED 发明人 GREEN JEREMY;CHAN CHUN KONG LAVAL;DAS SANJOY KUMAR;POISSON CARL;NANTHAKUMAR SUGANTHINI;WAAL NATHAN;LI PAN;RONKIN STEVEN;LAUFFER DAVID J.;WILSON DEAN M.
分类号 C07D417/12;A61K31/381;A61K31/422;A61K31/4245;A61K31/427;A61K31/4436;A61K31/4535;A61K31/497;A61K31/5377;A61K31/7056;A61K38/21;C07D333/40;C07D409/06;C07D409/12;C07D413/12 主分类号 C07D417/12
代理机构 代理人
主权项
地址